Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73


U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice.

Risso GS, Carabajal MV, Bruno LA, Ibañez AE, Coria LM, Pasquevich KA, Lee SJ, McSorley SJ, Briones G, Cassataro J.

Front Immunol. 2017 Feb 17;8:171. doi: 10.3389/fimmu.2017.00171. eCollection 2017.


An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.

Pasquevich KA, Ibañez AE, Coria LM, García Samartino C, Estein SM, Zwerdling A, Barrionuevo P, Oliveira FS, Seither C, Warzecha H, Oliveira SC, Giambartolomei GH, Cassataro J.

PLoS One. 2011 Jan 14;6(1):e16203. doi: 10.1371/journal.pone.0016203.


Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.

Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.

Infect Immun. 2009 Jan;77(1):436-45. doi: 10.1128/IAI.01151-08. Epub 2008 Nov 3. Erratum in: Infect Immun. 2009 Apr;77(4):1719.. Samartino, Clara García [corrected to García Samartino, Clara].


Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge.

Coria LM, Ibañez AE, Pasquevich KA, Cobiello PLG, Frank FM, Giambartolomei GH, Cassataro J.

Vaccine. 2016 Jan 20;34(4):430-437. doi: 10.1016/j.vaccine.2015.12.012. Epub 2015 Dec 17.


A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses.

Ibañez AE, Coria LM, Carabajal MV, Delpino MV, Risso GS, Cobiello PG, Rinaldi J, Barrionuevo P, Bruno L, Frank F, Klinke S, Goldbaum FA, Briones G, Giambartolomei GH, Pasquevich KA, Cassataro J.

J Control Release. 2015 Dec 28;220(Pt A):18-28. doi: 10.1016/j.jconrel.2015.10.011. Epub 2015 Oct 9.


Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.

Pascual DW, Hone DM, Hall S, van Ginkel FW, Yamamoto M, Walters N, Fujihashi K, Powell RJ, Wu S, Vancott JL, Kiyono H, McGhee JR.

Infect Immun. 1999 Dec;67(12):6249-56.


Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308.

Dabral N, Martha-Moreno-Lafont, Sriranganathan N, Vemulapalli R.

PLoS One. 2014 Sep 16;9(9):e107180. doi: 10.1371/journal.pone.0107180. eCollection 2014.


An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Khalil SM, Tonkin DR, Snead AT, Parks GD, Johnston RE, White LJ.

J Virol. 2014 Aug;88(16):9182-96. doi: 10.1128/JVI.00327-14. Epub 2014 Jun 4.


Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier.

Coria LM, Risso GS, Guaimas FF, Ferrero MC, Bruno L, Pasquevich KA, Cassataro J.

J Control Release. 2019 Jan 10;293:158-171. doi: 10.1016/j.jconrel.2018.11.025. Epub 2018 Nov 27.


Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.

Cong H, Gu QM, Jiang Y, He SY, Zhou HY, Yang TT, Li Y, Zhao QL.

Parasite Immunol. 2005 Jan-Feb;27(1-2):29-35.


New perspectives in vaccine development: mucosal immunity to infections.

McGhee JR, Kiyono H.

Infect Agents Dis. 1993 Apr;2(2):55-73. Review.


Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.

Zhao Z, Li M, Luo D, Xing L, Wu S, Duan Y, Yang P, Wang X.

Vaccine. 2009 Aug 20;27(38):5214-9. doi: 10.1016/j.vaccine.2009.06.075. Epub 2009 Jul 9.


Mucosal immunity: regulation by helper T cells and a novel method for detection.

Jackson RJ, Marinaro M, VanCott JL, Yamamoto M, Okahashi N, Fujihashi K, Kiyono H, Chatfield SN, McGhee JR.

J Biotechnol. 1996 Jan 26;44(1-3):209-16. Review.


The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis.

Pasquevich KA, García Samartino C, Coria LM, Estein SM, Zwerdling A, Ibañez AE, Barrionuevo P, Oliveira FS, Carvalho NB, Borkowski J, Oliveira SC, Warzecha H, Giambartolomei GH, Cassataro J.

J Immunol. 2010 May 1;184(9):5200-12. doi: 10.4049/jimmunol.0902209. Epub 2010 Mar 29.


[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.


Enhancement of host infectivity, immunity, and protective efficacy by addition of sodium bicarbonate antacid to oral vaccine formulation of live attenuated Salmonella secreting Brucella antigens.

Hewawaduge C, Senevirathne A, Lee JH.

Microb Pathog. 2019 Nov 6;138:103857. doi: 10.1016/j.micpath.2019.103857. [Epub ahead of print]


Mucosal responses to parenteral and mucosal vaccines.

Kaul D, Ogra PL.

Dev Biol Stand. 1998;95:141-6. Review.


Immunization of pregnant sows with a novel virulence gene deleted live Salmonella vaccine and protection of their suckling piglets against salmonellosis.

Hur J, Lee JH.

Vet Microbiol. 2010 Jul 14;143(2-4):270-6. doi: 10.1016/j.vetmic.2009.11.034. Epub 2009 Dec 3.


Supplemental Content

Support Center